COMMUNIQUÉ FROM EXTRAORDINARY GENERAL MEETING IN PROSTATYPE GENOMICS AB (PUBL) HELD ON 21 APRIL 2023
Prostatype Genomics AB (publ), listed on the Nasdaq First North Growth Market, held an extraordinary general meeting today on 21 April 2023, whereby the following decisions were made. In accordance with previously published information, the board decided on a preferential share issue on 22 March 2023, subject to the subsequent approval of the extraordinary general meeting. The general meeting has today resolved to approve the board's decision on the preferential share issue in accordance with the below. · One (1) current share in Prostatype Genomics held on the record date on 25